Conagen Stock
Conagen, a biotechnology company that focuses on bio-production of ingredients for food, pharmaceutical, and renewable materials industries.
Sign up today and learn more about Conagen Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Conagen Stock
Conagen is a biotechnology company that focuses on bio-production of ingredients for food, pharmaceutical, and renewable materials industries. Conagen is a discovery-based company. It is passionate about understanding and engineering metabolic pathways. Its scientists are equipped with unprecedented systemic information on cellular metabolism. Its engineers have developed new automation systems and novel fermentation technologies to advance its bio-manufacturing capabilities. The company was founded in 2010 and is headquartered in Bedford, Massachusetts.
Funding History
April 2020 | $30.0M |
---|
Management
Vice President, Research and Development
J. Casey Lippmeier
Co-Founder and CEO
Oliver Yu
Press
patents - Apr, 15 2024
Resilin-silica binding domain fusion proteins for biomaterial formationpatents - Apr, 15 2024
Compounds and methods for enhancing sweetness of sweetenerspatents - Apr, 15 2024
Methods of producing hydroxytyrosolpatents - Apr, 15 2024
Microorganisms and methods for producing menaquinone-7patents - Apr, 15 2024
Bioconversion of 4-coumaric acid to resveratrol